Rintatolimod drug molecules. Computer models of the TLR-3 (toll-like receptor) agonist Rintatolimod. It is being tested as a potential treatment for COVID-19.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP26298557
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
AGONISTARTWORKBLACKBACKGROUNDCOVID-19DRUGILLUSTRATIONMOLECULARMODELMOLECULARSTRUCTUREMOLECULENO-ONENOBODYBIOLOGYBIOLOGICALPHARMACEUTICALPHARMACEUTICSPHARMACOLOGICALPHARMACOLOGYPROTEINSARS-COV-22019-NCOVCORONAVIRUSCORONAVIRUSCOVIDCOVID-19DISEASEHCOVINFECTIOUSMICROBIOLOGICALMICROBIOLOGYSARS-COV-2VIRALVIRUSTLR-3TREATMENTRINTATOLIMODMOLECULARDISORDERCONDITION
2019-NCOVAGONISTARTWORKBACKGROUNDBIOLOGICALBIOLOGYBLACKCONDITIONCORONACORONAVIRUSCOVIDCOVID-19COVID-19DISEASEDISORDERDRUGHCOVILLUSTRATIONINFECTIOUSMICROBIOLOGICALMICROBIOLOGYMODELMOLECULARMOLECULARMOLECULARMOLECULENO-ONENOBODYPHARMACEUTICALPHARMACEUTICSPHARMACOLOGICALPHARMACOLOGYPROTEINRINTATOLIMODSARS-COV-2SARS-COV-2STRUCTURETLR-3TREATMENTVIRALVIRUSVIRUS